MOSUNETUZUMAB for Marginal zone lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where MOSUNETUZUMAB was used for Marginal zone lymphoma.

Most Reported Side Effects for MOSUNETUZUMAB

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	96	19.0%	7	74
Disease progression	65	12.9%	17	4
Covid-19	50	9.9%	8	26
Neutropenia	39	7.7%	4	7
Death	38	7.5%	38	2
Covid-19 pneumonia	37	7.3%	16	35
Malignant neoplasm progression	37	7.3%	26	2
Disorientation	31	6.1%	31	0
Neurological symptom	31	6.1%	31	0
Vasogenic cerebral oedema	31	6.1%	31	0
Pneumonia	30	5.9%	14	15
Off label use	29	5.7%	18	2
Diffuse large b-cell lymphoma recurrent	28	5.5%	28	0
Therapy partial responder	26	5.1%	25	0
Pyrexia	23	4.6%	2	12